
Montymo FX AB 10mg/120mg/200mg Tablet SR
Marketer
Morepen Laboratories Ltd
Salt Composition
Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg)
Overview Montymo FX AB 10mg/120mg/200mg Tablet SR
Asthmalin Trio 10mg/120mg/200mg Extended-Release Tablets are a multi-component medication employed for asthma prophylaxis. This formulation alleviates allergic manifestations including nasal discharge, nasal congestion, sneezing, lacrimation, and respiratory tract congestion. It facilitates bronchodilation by relaxing airway muscles, thereby improving airflow. Asthmalin Trio 10mg/120mg/200mg Extended-Release Tablets are administered with or without food, as directed by your physician, in a dosage and duration determined by your individual response and health status. Continuous use, as prescribed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all concurrent medications, as interactions may occur. Common adverse effects include nausea, vomiting, abdominal pain, diarrhea, rash, pruritus, dyspnea, and cephalalgia. Most are transient and self-limiting. Report any concerning side effects immediately to your doctor. Drowsiness and dizziness are possible; avoid driving or activities demanding alertness until effects are known. Alcohol consumption should be avoided due to potential synergistic sedative effects. Prior to commencing treatment, disclose any hepatic or renal impairment to allow for appropriate dosage adjustment. Likewise, inform your physician of pregnancy, pregnancy intentions, or breastfeeding.
Uses of Montymo FX AB 10mg/120mg/200mg Tablet SR
Chronic obstructive pulmonary disease
Major Benefits of Montymo FX AB 10mg/120mg/200mg Tablet SR:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Montymo FX AB 10mg/120mg/200mg Sustained-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Montymo FX AB 10mg/120mg/200mg Tablet SR:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Increased white blood cell count
- Increased transaminase level in blood
- Upper respiratory tract infection
- Constipation
- Abdominal discomfort
- Abdominal distension
- Heartburn
- Loss of appetite
- Esophageal bleeding
- Nasal inflammation
How to use Montymo FX AB 10mg/120mg/200mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Montymo FX AB 10mg/120mg/200mg Extended-Release Tablets can be consumed with or without food, however, consistent daily timing is recommended.
How Montymo FX AB 10mg/120mg/200mg Tablet SR works:
Montymo FX AB tablets (10mg/120mg/200mg sustained-release) combine montelukast, fexofenadine, and acebrophylline to address allergy and respiratory symptoms. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thus lessening airway and nasal inflammation and alleviating allergy symptoms. Fexofenadine, an antihistamine, provides relief from allergic manifestations such as rhinorrhea, lacrimation, and sneezing. Acebrophylline, a mucolytic agent, facilitates expectoration by reducing mucus viscosity.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Montymo FX AB 10mg/120mg/200mg SR tablets with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The extended-release Montymo FX AB 10mg/120mg/200mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Montymo FX AB 10mg/120mg/200mg sustained-release tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, dizziness, blurred vision, or reduced alertness after taking Montymo FX AB 10mg/120mg/200mg SR tablets. These side effects are possible.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Montymo FX AB 10mg/120mg/200mg sustained-release tablets. Dosage modification of Montymo FX AB 10mg/120mg/200mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Montymo FX AB 10mg/120mg/200mg extended-release tablets in patients with liver disease is likely safe. Current evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Montymo FX AB 10mg/120mg/200mg Tablet SR :
Should you forget a Montymo FX AB 10mg/120mg/200mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Montymo FX AB 10mg/120mg/200mg Tablet SR
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Breathing |